This is an over the counter product - it does not require prescription.
Ships on ICE, Please choose 2nd day Shipping for this item. For Canada customers, please choose Worldwide Saver as the shipping method.
For the immunization of healthy susceptible puppies and adult dogs against
canine upper respiratory disease complex (kennel cough) caused by canine parainfluenza
and bordetella bronchiseptica. Contains modified live parainfluenza virus and
avirulent live culture of bordetella. Dosage: Administer 1 ml intranasally in
the anterior nostril as the animal inhales. Revaccinate annually.
Vaccine: Canine Parainfluenza-Bordetella Bronchiseptica Vaccine, Modified
Live Virus, Avirulent Live Culture
Contents: This product contains the antigens listed above.
Indications: For vaccination of healthy susceptible dogs and puppies
against Canine Upper Respiratory Infection (Canine Cough) caused by canine parainfluenza
and Bordetella bronchiseptica.
Field studies support the safety of NARAMUNE-2 when administered to puppies
as young as 3 weeks of age.
Dosage and Administration:
Rehydration: Rehydrate to desired dose volume with accompanying sterile diluent.
For five 0.5 mL doses, reconstitute with 2.5 mL of diluent. For five 1 mL doses,
reconstitute with 5 mL of diluent. Shake well and use immediately.Using aseptic
technique, administer entire dose intranasally. Use enclosed applicator tip
on hub of syringe in place of syringe needle. Apply new nasal applicator tip
for each dog vaccinated.
Do not vaccinate puppies under 3 weeks of age.
Puppies vaccinated between 3 and 6 weeks of age should be revaccinated at 6
weeks of age.
Annual revaccination is recommended.
Precaution(s): Store out of direct sunlight at a temperature between
35-45°F (2-7°C). Use entire contents when first opened. Burn containers
and all unused contents.
Caution(s): For intranasal use in dogs only; do not vaccinate dogs parenterally.
Anaphylactoid reactions may occur.
Description and General Information: NARAMUNE-2 Canine Parainfluenza Vaccine,
Modified Live Virus, Bordetella Bronchiseptica Vaccine, Avirulent Live Culture
is designed to be administered intranasally for convenient, rapid prevention
of Canine Upper Respiratory Infection (Canine Cough).
Both of these organisms are widespread, common etiologic agents of this syndrome
which appears as a mild, self-limiting disease involving the trachea and bronchi
of dogs of any age. It spreads rapidly among dogs that are closely confined
as in hospitals, kennels and pet stores.
The disease is highly contagious and is transmitted via the airborne route.Both
of the organisms in NARAMUNE-2 are avirulent so that they can be safely administered
intranasally with little or no symptoms of disease. By instilling these organisms
into the nasal passages, it becomes possible for these agents to infect target
cells of the nasal-pharyngeal region, mimicking the pathogenesis of natural
A very small percentage of dogs may show sneezing, coughing or nasal discharge
for 3-10 days following vaccination. While these are usually temporary symptoms,
antibacterial therapy may be indicated. .